% bmc_article.bib
% 
%  An example of bibtex entries.
%  Entries taken from BMC instructions for authors page.

% uncomment next line to make author-year bibliography
% @settings{label, options="nameyear"}

% Ainhoa (Demencia)
@article{Formiga2009,
  title = {Demencia, una enfermedad evolutiva: demencia severa. Identificación de demencia terminal},
  author = {Formiga, Francesc and Robles, M. José and Fort, Isabel},
  journal = {Revista Española de Geriatría y Gerontología},
  volume = {44},
  pages = {2--8},
  year = {2009},
  issn = {0211-139X},
  doi = {10.1016/j.regg.2009.05.009}
}
% Ainhoa (Demencia)
@report{Long2023,
  title 	= {World Alzheimer Report 2023: Reducing dementia risk: never too early, never too late},
  author	= {Simon Long and Chloé Benoist and Wendy Weidner},
  institution = {Alzheimer’s Disease International},
  year  	= {2023},
  month 	= {September},
  note  	= {Published by Alzheimer’s Disease International (ADI), London.}
}
% Ainhoa (Demencia)
@article{GOODMAN201728,
title = {Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011–2013},
journal = {Alzheimer's \& Dementia},
volume = {13},
number = {1},
pages = {28-37},
year = {2017},
issn = {1552-5260},
doi = {https://doi.org/10.1016/j.jalz.2016.04.002},
author = {Richard A. Goodman and Kimberly A. Lochner and Madhav Thambisetty and Thomas S. Wingo and Samuel F. Posner and Shari M. Ling},
keywords = {Alzheimer's disease, Dementia, Epidemiology, Medicare, Prevalence, Subtypes}
}

% Ainhoa (Demencia)
@report{GarreOlmo2016,
  title 	= {Memòria d’activitat del Registre de Demències de Girona 2016},
  author	= {Garre-Olmo, Josep and others},
  institution = {Registre de Demències de Girona (ReDeGi)},
  year  	= {2016},
  url   	= {https://www.ias.cat/adjunts/files/MemoriaReDeGi2016.pdf},
  note  	= {Institut d’Assistència Sanitària, Girona},
}

%Carmen. Análisis bibliográfico de la demencia frontotemporal
@article{fneur.2024.1399600,
	
	AUTHOR={Chen, Xinxin  and Chen, Yin  and Ni, Biyu  and Huang, Cheng },
	
	TITLE={Research trends and hotspots for frontotemporal dementia from 2000 to 2022: a bibliometric analysis},
	
	JOURNAL={Frontiers in Neurology},
	
	VOLUME={15},
	
	YEAR={2024},
	
	URL={https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1399600},
	
	DOI={10.3389/fneur.2024.1399600},
	
	ISSN={1664-2295}
	
	}


%Carmen. Relación DTF y ELA
@article{Root2021,
	abstract = {Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are fatal neurodegenerative disorders that are thought to exist on a clinical and pathological spectrum. FTD and ALS are linked by shared genetic causes (e.g. C9orf72 hexanucleotide repeat expansions) and neuropathology, such as inclusions of ubiquitinated, misfolded proteins (e.g. TAR DNA-binding protein 43; TDP-43) in the CNS. Furthermore, some genes that cause FTD or ALS when mutated encode proteins that localize to the lysosome or modulate endosome-lysosome function, including lysosomal fusion, cargo trafficking, lysosomal acidification, autophagy, or TFEB activity. In this review, we summarize evidence that lysosomal dysfunction, caused by genetic mutations (e.g. C9orf72, GRN, MAPT, TMEM106B) or toxic-gain of function (e.g. aggregation of TDP-43 or tau), is an important pathogenic disease mechanism in FTD and ALS. Further studies into the normal function of many of these proteins are required and will help uncover the mechanisms that cause lysosomal dysfunction in FTD and ALS. Mutations or polymorphisms in genes that encode proteins important for endosome-lysosome function also occur in other age-dependent neurodegenerative diseases, including Alzheimer's (e.g. APOE, PSEN1, APP) and Parkinson's (e.g. GBA, LRRK2, ATP13A2) disease. A more complete understanding of the common and unique features of lysosome dysfunction across the spectrum of neurodegeneration will help guide the development of therapies for these devastating diseases.},
	author = {Jessica Root and Paola Merino and Austin Nuckols and Michelle Johnson and Thomas Kukar},
	doi = {10.1016/J.NBD.2021.105360},
	issn = {0969-9961},
	journal = {Neurobiology of Disease},
	keywords = {Alzheimer's disease and related dementias (ADRD),Amyotrophic lateral sclerosis (ALS),Autophagy,C9orf72,Frontotemporal dementia (FTD),Frontotemporal lobar degeneration (FTLD),Granulins (GRNs),Lysosome dysfunction,Microtubule-associated protein tau (MAPT),Neurodegeneration,Progranulin (PGRN),Transactive response DNA binding protein 43 kDa (TDP-43),Transcription factor EB (TFEB),Transmembrane protein 106B (TMEM106B),Ubiquitin},
	month = {7},
	pages = {105360},
	pmid = {33812000},
	publisher = {Academic Press},
	title = {Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis},
	volume = {154},
	year = {2021},
}

%Carmen Similitudes patológicas
@article{Casterton2020,
	abstract = {Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) constitute aggressive neurodegenerative pathologies that lead to the progressive degeneration of upper and lower motor neurons and of neocortical areas, respectively. In the past decade, the identification of several genes that cause these disorders indicated that the two diseases overlap in a multifaceted spectrum of conditions. The autophagy-lysosome system has been identified as a main intersection for the onset and progression of neurodegeneration in ALS/FTD. Genetic evidence has revealed that several genes with a mechanistic role at different stages of the autophagy process are mutated in patients with ALS/FTD. Moreover, the three main proteins aggregating in ALS/FTD, including in sporadic cases, are also targeted by autophagy and affect this process. Here, we examine the varied dysfunctions and degrees of involvement of the autophagy-lysosome system that have been discovered in ALS/FTD. We argue that these findings shed light on the pathological mechanisms in the ALS/FTD spectrum and conclude that they have important consequences both for treatment options and for the basic biomolecular understanding of how this process intersects with RNA metabolism, the other major cellular process reported to be dysfunctional in part of the ALS/FTD spectrum.},
	author = {R.L. Casterton and R.J. Hunt and M. Fanto},
	doi = {10.1016/j.jmb.2020.02.018},
	issue = {8},
	journal = {Journal of Molecular Biology},
	pages = {2692-2713},
	title = {Pathomechanism Heterogeneity in the Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disease Spectrum: Providing Focus Through the Lens of Autophagy},
	volume = {432},
	year = {2020},
}
@article{Arai2006,
	abstract = {Ubiquitin-positive tau-negative neuronal cytoplasmic inclusions and dystrophic neurites are common pathological features in frontotemporal lobar degeneration (FTLD) with or without symptoms of motor neuron disease and in amyotrophic lateral sclerosis (ALS). Using biochemical and immunohistochemical analyses, we have identified a TAR DNA-binding protein of 43 kDa (TDP-43), a nuclear factor that functions in regulating transcription and alternative splicing, as a component of these structures in FTLD. Furthermore, skein-like inclusions, neuronal intranuclear inclusions, and glial inclusions in the spinal cord of ALS patients are also positive for TDP-43. Dephosphorylation treatment of the sarkosyl insoluble fraction has shown that abnormal phosphorylation takes place in accumulated TDP-43. The common occurrence of intracellular accumulations of TDP-43 supports the hypothesis that these disorders represent a clinicopathological entity of a single disease, and suggests that they can be newly classified as a proteinopathy of TDP-43. © 2006 Elsevier Inc. All rights reserved.},
	author = {T. Arai and M. Hasegawa and H. Akiyama and K. Ikeda and T. Nonaka and H. Mori and D. Mann and K. Tsuchiya and M. Yoshida and Y. Hashizume and Y. Hashizume and T. Oda},
	doi = {10.1016/j.bbrc.2006.10.093},
	issue = {3},
	journal = {Biochemical and Biophysical Research Communications},
	pages = {602-611},
	title = {TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis},
	volume = {351},
	year = {2006},
}

%Carmen. ELA y DFT relación con C9orf72
@article{Balendra2018,
	abstract = {The discovery that repeat expansions in the C9orf72 gene are a frequent cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) has revolutionized our understanding of these diseases. Substantial headway has been made in characterizing C9orf72-mediated disease and unravelling its underlying aetiopathogenesis. Three main disease mechanisms have been proposed: loss of function of the C9orf72 protein and toxic gain of function from C9orf72 repeat RNA or from dipeptide repeat proteins produced by repeat-associated non-ATG translation. Several downstream processes across a range of cellular functions have also been implicated. In this article, we review the pathological and mechanistic features of C9orf72-associated FTD and ALS (collectively termed C9FTD/ALS), the model systems used to study these conditions, and the probable initiators of downstream disease mechanisms. We suggest that a combination of upstream mechanisms involving both loss and gain of function and downstream cellular pathways involving both cell-autonomous and non-cell-autonomous effects contributes to disease progression. Repeat expansions in the C9orf72 gene are a frequent cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Balendra and Isaacs review the pathological and mechanistic features of C9orf72-associated ALS and FTD, highlighting loss-of-function, gain-of-function and downstream mechanisms.},
	author = {Rubika Balendra and Adrian M. Isaacs},
	doi = {10.1038/s41582-018-0047-2},
	isbn = {4158201800472},
	issn = {1759-4766},
	issue = {9},
	journal = {Nature Reviews Neurology 2018 14:9},
	keywords = {Amyotrophic lateral sclerosis,Dementia,RNA metabolism},
	month = {8},
	pages = {544-558},
	pmid = {30120348},
	publisher = {Nature Publishing Group},
	title = {C9orf72-mediated ALS and FTD: multiple pathways to disease},
	volume = {14},
	url = {https://www.nature.com/articles/s41582-018-0047-2},
	year = {2018},
}
%Carmen Diferencia entre ELA y MND
@misc{NHS_MND,
	author       = {{NHS Inform}},
	title        = {Motor Neurone Disease (MND)},
	year         = {n.d.},
	url          = {https://www.nhsinform.scot/illnesses-and-conditions/brain-nerves-and-spinal-cord/motor-neurone-disease-mnd/},
	note         = {Accessed: 2024-10-04}
}

% Carmen MND
@article{Devenney2015,
	abstract = {Motor neuron disease (MND) and frontotemporal dementia (FTD), once considered distinct disorders, are now recognized to form a continuum, with pure MND at one end of the spectrum and pure FTD at th...},
	author = {Emma Devenney and Steve Vucic and John R. Hodges and Matthew C. Kiernan},
	doi = {10.1586/14737175.2015.1034108},
	issn = {17448360},
	issue = {5},
	journal = {Expert Review of Neurotherapeutics},
	keywords = {C9orf72,Frontotemporal dementia,behavior,clinical continuum,cognition,genetics,motor neuron disease,neuroimaging,neurophysiology},
	month = {5},
	pages = {509-522},
	pmid = {25865485},
	publisher = {Informa Healthcare},
	title = {Motor neuron disease-frontotemporal dementia: a clinical continuum},
	volume = {15},
	url = {https://www.tandfonline.com/doi/abs/10.1586/14737175.2015.1034108},
	year = {2015},
}

%Carmen FTD and MND
@article{Devenney2019,
	abstract = {Frontotemporal dementia (FTD) is the second commonest cause of young onset dementia. Our understanding of FTD and its related syndromes has advanced significantly in recent years. Among the most prominent areas of progress is the overlap between FTD, MND, and other neurodegenerative conditions at a clinicopathologic and genetic level. In parallel major advances in neuroimaging techniques, the discovery of new genetic mutations as well as the development of potential biomarkers may serve to further expand knowledge of the biologic processes at play in FTD and may in turn propel research toward identifying curative and preventative pharmacologic therapies. The aim of this chapter is to discuss the clinical, pathologic, and genetic complexities of FTD and related disorders.},
	author = {Emma M. Devenney and Rebekah M. Ahmed and John R. Hodges},
	doi = {10.1016/B978-0-12-804766-8.00015-7},
	issn = {0072-9752},
	journal = {Handbook of Clinical Neurology},
	keywords = {Behavioral variant frontotemporal dementia,Biomarkers,C9orf72,Frontotemporal lobar degeneration,Motor neuron disease,Neuroimaging,Pharmacologic therapy,Primary progressive aphasia},
	month = {1},
	pages = {279-299},
	pmid = {31753137},
	publisher = {Elsevier},
	title = {Frontotemporal dementia},
	volume = {167},
	year = {2019},
}

%Carmen. Sindrome corticobasal
@misc{Orphanet_MND,
	author       = {{Orphanet}},
	title        = {Enfermedad neurológica poco frecuente},
	year         = {n.d.},
	note         = {Accessed: 2024-10-04}
}

% Carmen. Prueba relación entre ELA( MND) y FTD
@article{10.1093/brain/awr195,
	author = {Burrell, James R. and Kiernan, Matthew C. and Vucic, Steve and Hodges, John R.},
	title = "{Motor Neuron dysfunction in frontotemporal dementia}",
	journal = {Brain},
	volume = {134},
	number = {9},
	pages = {2582-2594},
	year = {2011},
	month = {08},
	abstract = "{Frontotemporal dementia and motor neuron disease share clinical, genetic and pathological characteristics. Motor neuron disease develops in a proportion of patients with frontotemporal dementia, but the incidence, severity and functional significance of motor system dysfunction in patients with frontotemporal dementia has not been determined. Neurophysiological biomarkers have been developed to document motor system dysfunction including: short-interval intracortical inhibition, a marker of corticospinal motor neuron dysfunction and the neurophysiological index, a marker of lower motor neuron dysfunction. The present study performed detailed clinical and neurophysiological assessments on 108 participants including 40 consecutive patients with frontotemporal dementia, 42 age- and gender-matched patients with motor neuron disease and 26 control subjects. Of the 40 patients with frontotemporal dementia, 12.5\% had concomitant motor neuron disease. A further 27.3\% of the patients with frontotemporal dementia had clinical evidence of minor motor system dysfunction such as occasional fasciculations, mild wasting or weakness. Biomarkers of motor system function were abnormal in frontotemporal dementia. Average short-interval intracortical inhibition was reduced in frontotemporal dementia (4.3 ± 1.7\%) compared with controls (9.1 ± 1.1\%, P \\&lt; 0.05). Short-interval intracortical inhibition was particularly reduced in the progressive non-fluent aphasia subgroup, but was normal in patients with behavioural variant frontotemporal dementia and semantic dementia. The neurophysiological index was reduced in frontotemporal dementia (1.1) compared with controls (1.9, P \\&lt; 0.001), indicating a degree of lower motor neuron dysfunction, although remained relatively preserved when compared with motor neuron disease (0.7, P \\&lt; 0.05). Motor system dysfunction in frontotemporal dementia may result from pathological involvement of the primary motor cortex, with secondary degeneration of lower motor neurons in the brainstem and anterior horn of the spinal cord.}",
	issn = {0006-8950},
	doi = {10.1093/brain/awr195},
	url = {https://doi.org/10.1093/brain/awr195},
	eprint = {https://academic.oup.com/brain/article-pdf/134/9/2582/17869835/awr195.pdf},
}

%Carmen Gen C9ORF72 asociación con ELA y FTD
@article{DeJesusHernandez2011,
	author = {Mariely DeJesus-Hernandez and Ian R. Mackenzie and Bradley F. Boeve and Adam L. Boxer and Matt Baker and Nicola J. Rutherford and Alexandra M. Nicholson and Ni Cole A. Finch and Heather Flynn and Jennifer Adamson and Naomi Kouri and Aleksandra Wojtas and Pheth Sengdy and Ging Yuek R. Hsiung and Anna Karydas and William W. Seeley and Keith A. Josephs and Giovanni Coppola and Daniel H. Geschwind and Zbigniew K. Wszolek and Howard Feldman and David S. Knopman and Ronald C. Petersen and Bruce L. Miller and Dennis W. Dickson and Kevin B. Boylan and Neill R. Graff-Radford and Rosa Rademakers},
	doi = {10.1016/J.NEURON.2011.09.011/ATTACHMENT/095EB372-EA80-49C0-886D-91026D6299DE/MMC1.PDF},
	issn = {08966273},
	issue = {2},
	journal = {Neuron},
	month = {10},
	pages = {245-256},
	pmid = {21944778},
	publisher = {Elsevier},
	title = {Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS},
	volume = {72},
	url = {http://www.cell.com/article/S0896627311008282/fulltext http://www.cell.com/article/S0896627311008282/abstract https://www.cell.com/neuron/abstract/S0896-6273(11)00828-2},
	year = {2011},
}

% Carmen Gen OPTN
@article{Bussi2018,
	abstract = {Autophagic dysfunction and protein aggregation have been linked to several neurodegenerative disorders, but the exact mechanisms and causal connections are not clear and most previous work was done in neurons and not in microglial cells. Here, we report that exogenous fibrillary, but not monomeric, alpha-synuclein (AS, also known as SNCA) induces autophagy in microglial cells. We extensively studied the dynamics of this response using both live-cell imaging and correlative light-electron microscopy (CLEM), and found that it correlates with lysosomal damage and is characterised by the recruitment of the selective autophagy-associated proteins TANK-binding kinase 1 (TBK1) and optineurin (OPTN) to ubiquitylated lysosomes. In addition, we observed that LC3 (MAP1LC3B) recruitment to damaged lysosomes was dependent on TBK1 activity. In these fibrillar AS-treated cells, autophagy inhibition impairs mitochondrial function and leads to microglial cell death. Our results suggest that microglial autophagy is induced in response to lysosomal damage caused by persistent accumulation of AS fibrils. Importantly, triggering of the autophagic response appears to be an attempt at lysosomal quality control and not for engulfment of fibrillar AS.},
	author = {Claudio Bussi and Javier M. Peralta Ramos and Daniela S. Arroyo and Jose I. Gallea and Paolo Ronchi and Androniki Kolovou and Ji M. Wang and Oliver Florey and Maria S. Celej and Yannick Schwab and Nicholas T. Ktistakis and Pablo Iribarren},
	doi = {10.1242/JCS.226241/VIDEO-13},
	issn = {14779137},
	issue = {23},
	journal = {Journal of Cell Science},
	keywords = {Alpha-synuclein,Autophagy,Cell death,Lysosomes,Microglia},
	month = {12},
	pmid = {30404831},
	publisher = {Company of Biologists Ltd},
	title = {Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells},
	volume = {131},
	url = {/pmc/articles/PMC6518333/ /pmc/articles/PMC6518333/?report=abstract https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518333/},
	year = {2018},
}

% La FTD como un fenotipo clínico (Mario, Introducción)
@article{rohrer2011phenotypic,
	title={Phenotypic signatures of genetic frontotemporal dementia},
	author={Rohrer, Jonathan D and Warren, Jason D},
	journal={Current opinion in neurology},
	volume={24},
	number={6},
	pages={542--549},
	year={2011},
	publisher={LWW}
}


% Artículo de introducción a la FTD (Mario, Introducción)
@article{pan2013clinic,
	title={Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review},
	author={Pan, Xiao-dong and Chen, Xiao-chun},
	journal={Translational neurodegeneration},
	volume={2},
	pages={1--9},
	year={2013},
	publisher={Springer}
}

% Rangos de edad y características generales de la FTD (Mario, Introducción)
@article{snowden2002frontotemporal,
	title={Frontotemporal dementia},
	author={Snowden, Julie S and Neary, David and Mann, David MA},
	journal={The British journal of psychiatry},
	volume={180},
	number={2},
	pages={140--143},
	year={2002},
	publisher={Cambridge University Press}
}

% Ensayo clínico para determinar rangos de edad y localización de la enfermedad
% en determinados grupos de pacientes. (Mario, Introducción)
@article{ratnavalli2002prevalence,
	title={The prevalence of frontotemporal dementia},
	author={Ratnavalli, E and Brayne, C and Dawson, K and Hodges, JR},
	journal={Neurology},
	volume={58},
	number={11},
	pages={1615--1621},
	year={2002},
	publisher={AAN Enterprises}
}

% Introducción a la enfermedad de alzheimer (Mario, Introducción)
@article{castellani2010alzheimer,
	title={Alzheimer disease},
	author={Castellani, Rudy J and Rolston, Raj K and Smith, Mark A},
	journal={Disease-a-month: DM},
	volume={56},
	number={9},
	pages={484},
	year={2010},
	publisher={NIH Public Access}
}

% Introducción a la bvFTD (Mario, Introducción)
@article{piguet2011behavioural,
	title={Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management},
	author={Piguet, Olivier and Hornberger, Michael and Mioshi, Eneida and Hodges, John R},
	journal={The Lancet Neurology},
	volume={10},
	number={2},
	pages={162--172},
	year={2011},
	publisher={Elsevier}
}

% Justificación de fenotipos de la FTD (Mario, Introducción)
@article{lillo2010neurobehavioral,
	title={Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis},
	author={Lillo, Patricia and Garcin, Beatrice and Hornberger, Michael and Bak, Thomas H and Hodges, John R},
	journal={Archives of neurology},
	volume={67},
	number={7},
	pages={826--830},
	year={2010},
	publisher={American Medical Association}
}


% Tipos de PPA (Mario, Introducción)
@article{gorno2011classification,
	title={Classification of primary progressive aphasia and its variants},
	author={Gorno-Tempini, Maria Luisa and Hillis, Argye E and Weintraub, Sandra and Kertesz, Andrew and Mendez, Mario and Cappa, Stefano F and Ogar, Jennifer M and Rohrer, Jonathan D and Black, Steven and Boeve, Bradley F and others},
	journal={Neurology},
	volume={76},
	number={11},
	pages={1006--1014},
	year={2011},
	publisher={AAN Enterprises}
}

% Proteína tau relacionado con la FTD neuropatológica (Mario, Introducción)
@article{mackenzie2010tau,
	title={TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia},
	author={Mackenzie, Ian RA and Rademakers, Rosa and Neumann, Manuela},
	journal={The Lancet Neurology},
	volume={9},
	number={10},
	pages={995--1007},
	year={2010},
	publisher={Elsevier}
}

# Ubiquitina y TDP-43 relacionada con la neuropatología de la FTD (Mario, Introducción)
@article{mackenzie2008atypical,
	title={Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions},
	author={Mackenzie, Ian RA and Foti, Dean and Woulfe, John and Hurwitz, Trevor A},
	journal={Brain},
	volume={131},
	number={5},
	pages={1282--1293},
	year={2008},
	publisher={Oxford University Press}
}

# TDP-43 y proteínas FUS en FTD (Mario, Introducción)
@article{mackenzie2010tdp,
	title={TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia},
	author={Mackenzie, Ian RA and Rademakers, Rosa and Neumann, Manuela},
	journal={The Lancet Neurology},
	volume={9},
	number={10},
	pages={995--1007},
	year={2010},
	publisher={Elsevier}
}

% SPECT para diagnóstico (Mario, Introducción)
@article{varma2002spect,
	title={Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia},
	author={Varma, AR and Adams, W and Lloyd, JJ and Carson, KJ and Snowden, JS and Testa, HJ and Jackson, A and Neary, D},
	journal={Acta neurologica scandinavica},
	volume={105},
	number={4},
	pages={261--269},
	year={2002},
	publisher={Wiley Online Library}
}

% FDG-PET para diagnóstico (Mario, Introducción)
@article{kanda2008fdgpet,
	title={Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies},
	author={Kanda, Tomonori and Ishii, Kazunari and Uemura, Takafumi and Miyamoto, Naokazu and Yoshikawa, Toshiki and Kono, Atsushi K and Mori, Etsuro},
	journal={European journal of nuclear medicine and molecular imaging},
	volume={35},
	pages={2227--2234},
	year={2008},
	publisher={Springer}
}

% Beta amiloide para diagnostico futuro con imagen neuro (Mario, Introducción)
@article{rowe2007imagingamiloid,
	title={Imaging $\beta$-amyloid burden in aging and dementia},
	author={Rowe, Christopher C and Ng, Steven and Ackermann, Uwe and Gong, Sylvia J and Pike, K and Savage, Greg and Cowie, Tiffany F and Dickinson, Kerryn L and Maruff, Paul and Darby, David and others},
	journal={Neurology},
	volume={68},
	number={20},
	pages={1718--1725},
	year={2007},
	publisher={AAN Enterprises}
}

% Genes FTD (Mario, Introducción)
@article{sirkis2019recentgenes,
	title={Recent advances in the genetics of frontotemporal dementia},
	author={Sirkis, Daniel W and Geier, Ethan G and Bonham, Luke W and Karch, Celeste M and Yokoyama, Jennifer S},
	journal={Current genetic medicine reports},
	volume={7},
	pages={41--52},
	year={2019},
	publisher={Springer}
}

% Imagen neuro comparacion patologia (Mario, Introducción)
@article{peet2021neuroimaging,
	title={Neuroimaging in frontotemporal dementia: heterogeneity and relationships with underlying neuropathology},
	author={Peet, Bradley T and Spina, Salvatore and Mundada, Nidhi and La Joie, Renaud},
	journal={Neurotherapeutics},
	volume={18},
	number={2},
	pages={728--752},
	year={2021},
	publisher={Elsevier}
}

% FTLD introduction an consensus (Mario, Introducción)
@article{neary1998frontotemporal,
	title={Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria},
	author={Freedman, M and Robert, PH and others},
	journal={Neurology},
	volume={51},
	number={6},
	pages={1546--1554},
	year={1998},
	publisher={AAN Enterprises}
}

% Artículo de MAPT (Gonzalo, Causas genéticas)
@article{caillet2015regulation,
	title={Regulation of human MAPT gene expression},
	author={Caillet-Boudin, Marie-Laure and Bu{\'e}e, Luc and Sergeant, Nicolas and Lefebvre, Bruno},
	journal={Molecular neurodegeneration},
	volume={10},
	pages={1--14},
	year={2015},
	publisher={Springer}
}

% Artículo de GNR (Gonzalo, Causas genéticas)
@article{bateman2009granulin,
	title={The granulin gene family: from cancer to dementia},
	author={Bateman, Andrew and Bennett, Hugh PJ},
	journal={Bioessays},
	volume={31},
	number={11},
	pages={1245--1254},
	year={2009},
	publisher={Wiley Online Library}
}

% Artículo de C9ORF72 (Gonzalo, Causas genéticas)
@article{mackenzie2014neuropathology,
	title={The neuropathology associated with repeat expansions in the C9ORF72 gene},
	author={Mackenzie, Ian RA and Frick, Petra and Neumann, Manuela},
	journal={Acta neuropathologica},
	volume={127},
	pages={347--357},
	year={2014},
	publisher={Springer}
}

% Artículo de TARDBP (Gonzalo, Causas genéticas)
@article{borroni2010tardbp,
	title={TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course},
	author={Borroni, Barbara and Archetti, S and Del Bo, R and Papetti, A and Buratti, E and Bonvicini, C and Agosti, Chiara and Cosseddu, Maura and Turla, M and Di Lorenzo, D and others},
	journal={Rejuvenation research},
	volume={13},
	number={5},
	pages={509--517},
	year={2010},
	publisher={Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA}
}

% Artículo de VCP (Gonzalo, Causas genéticas)
@article{wong2018three,
	title={Three VCP mutations in patients with frontotemporal dementia},
	author={Wong, Tsz Hang and Pottier, Cyril and Hondius, David C and Meeter, Lieke HH and Van Rooij, Jeroen GJ and Melhem, Shami and Netherlands Brain bank and van Minkelen, Rick and van Duijn, Cornelia M and Rozemuller, Annemieke JM and others},
	journal={Journal of Alzheimer’s Disease},
	volume={65},
	number={4},
	pages={1139--1146},
	year={2018},
	publisher={SAGE Publications Sage UK: London, England}
}

% Artículo de CHM02B (Gonzalo, Causas genéticas)
@article{m2011frontotemporal,
	title={Frontotemporal dementia caused by CHMP2B mutations},
	author={M Isaacs, A and Johannsen, P and Holm, I and E Nielsen, J and others},
	journal={Current Alzheimer Research},
	volume={8},
	number={3},
	pages={246--251},
	year={2011},
	publisher={Bentham Science Publishers}
}

% Artículo de genética de la demencia frontotemporal (Gonzalo, Causas genéticas)
@article{granadillo2008genetica,
	title={Gen{\'e}tica de la demencia frontotemporal},
	author={Granadillo de Luque, Jorge Luis and Zarante, Ignacio},
	journal={Revista colombiana de psiquiatr{\'\i}a},
	volume={37},
	number={1},
	pages={94--112},
	year={2008},
	publisher={Asociacion Colombiana de Psiquiatria}
}

% Artículo de factores ambientales y medicos de riesgo en DFT  (Gonzalo, Causas genéticas)
@article{rosso2003medical,
	title={Medical and environmental risk factors for sporadic frontotemporal dementia: a retrospective case--control study},
	author={Rosso, SM and Landweer, EJ and Houterman, M and Kaat, L Donker and Van Duijn, CM and Van Swieten, JC},
	journal={Journal of Neurology, Neurosurgery \& Psychiatry},
	volume={74},
	number={11},
	pages={1574--1576},
	year={2003},
	publisher={BMJ Publishing Group Ltd}
}

% Artículo sobre la supervivencia y esperanza de vida en pacientes con DFT (Ainhoa Pérez, Introducción)
@article{Hodges2003,
	title={Survival in frontotemporal dementia},
	author={Hodges, John R and Davies, Ross and Xuereb, John and Casey, Barbara and Broe, Matthew and Bak, Thomas and Kril, Jillian and Halliday, Glenda},
	journal={Neurology},
	volume={61},
	number={3},
	pages={349--354},
	year={2003},
	publisher={Wolters Kluwer},
	url = {https://pubmed.ncbi.nlm.nih.gov/12913196/}
}

% Artículo sobre enfoques terapéuticos para DFT (Ainhoa Pérez, Introducción)
@article{SpringerLink2023,
	title = {New Approaches to the Treatment of Frontotemporal Dementia}, 
	author = {Neurotherapeutics},
	journal = {SpringerLink},
	year = {2023},
	url = {https://link.springer.com/article/10.1007/s13311-023-01380-6}
}

% Ensayo clínico de terapia génica para mutaciones en progranulina (Ainhoa Pérez, Introducción)
@misc{PassageBio2023,
	title = {upliFT-D: A Clinical Trial for Frontotemporal Dementia with Progranulin Gene Mutations},
	author = {Passage Bio},
	year = {2023},
	url = {https://passagebioclinicaltrials.com/Frontotemporal-Dementia/en/about-this-trial}
}

% Ensayos clínicos con medicamentos experimentales para demencia frontotemporal. (Ainhoa Pérez, Introducción)
@misc{MayoClinic2023,
	title = {Frontotemporal Dementia Clinical Trials - Mayo Clinic Research},
	author = {Mayo Clinic},
	year = {2023},
	url = {https://www.mayo.edu/research/clinical-trials/diseases-conditions/frontotemporal-dementia}
}

% Estudio sobre tratamientos con medicamentos para síntomas conductuales (Ainhoa Pérez, Introducción)
@misc{NINDS2023,
	title = {Treatment Study of Frontotemporal Dementia},
	author = {National Institute of Neurological Disorders and Stroke (NINDS)},
	year = {2023},
	url = {https://www.ninds.nih.gov/health-information/clinical-trials/treatment-study-frontotemporal-dementia}
}

% ----------------------------------------------------------
% Datos, HPO y STRING

@misc{hpo_api,
	author       = {{The Human Phenotype Ontology Consortium}},
	title        = {{HPO Ontology Annotation Network API}},
	year         = {2024},
	url          = {https://ontology.jax.org/api/network/docs},
	note         = {Accessed: 2024-11-05},
}

@misc{HPO,
	author       = {{The Human Phenotype Ontology Consortium}},
	title        = {{Human Phenotype Ontology}},
	year         = {2024},
	url          = {https://hpo.jax.org/},
	note         = {Accessed: 2024-11-05}
}

@misc{string_api,
	author       = {{Szklarczyk, Damian} and {Gable, Annika L.} and {Lyon, David} and {Junge, Alexander} and {Wyder, Stefan} and {Huerta-Cepas, Jaime} and {Simonovic, Milan} and {Doncheva, Nadezhda T.} and {Morris, John H.} and {Bork, Peer} and {et al.}},
	title        = {{STRING API}},
	year         = {2024},
	url          = {https://string-db.org/help/api/},
	note         = {Accessed: 2024-11-06},
}

% ----------------------------------------------------------
% PAQUETES DE PYTHON

@misc{pandas,
	author = {The pandas development team},
	title = {pandas: Powerful data structures for data analysis in Python},
	year = {2024},
	url = {https://pandas.pydata.org},
	note = {Versión 2.2.3}
}

@misc{matplotlib,
	author = {John D. Hunter},
	title = {Matplotlib: A 2D Graphics Environment},
	year = {2007},
	url = {https://matplotlib.org},
	note = {Versión 3.8.1},
	journal = {Computing in Science \& Engineering},
	volume = {9},
	number = {3},
	pages = {90--95}
}

@misc{scienceplots,
	title = {SciencePlots: Matplotlib styles for scientific figures},
	author = {Garrett L. Nelson},
	year = {2021},
	url = {https://github.com/garrettj403/SciencePlots},
	note = {Versión 2.1.1},
}

@misc{requests,
	author = {Kenneth Reitz and colaboradores de Requests},
	title = {Requests: HTTP for Humans},
	year = {2024},
	url = {https://docs.python-requests.org},
	note = {Versión 2.31.0}
}

@misc{goatools,
	author = {David V. Klopfenstein and Lucas Dangl and Adam Wilfert and Enrico Lombardot and Hirokazu S. Mariadassou and William Goetz},
	title = {GOATOOLS: A Python library for Gene Ontology analyses},
	year = {2018},
	url = {https://github.com/tanghaibao/goatools},
	note = {Versión 1.2.3}
}

@misc{gprofiler,
	author = {Riikka Räty and Tuuli Lappalainen y otros},
	title = {gProfiler: A web server for functional enrichment analysis and conversions of gene lists},
	year = {2019},
	url = {https://github.com/biit/gprofiler},
	note = {Versión 1.4.0}
}

@misc{statsmodels,
	author = {Skipper Seabold y Josef Perktold},
	title = {Statsmodels: Econometric and statistical modeling with Python},
	year = {2010},
	url = {https://www.statsmodels.org},
	note = {Versión 0.15.0}
}

% ----------------------------------------------------------
% PAQUETES DE R
@manual{cluster,
	author = {Martin Maechler, Peter Rousseeuw, Anja Struyf, Mia Hubert y Kurt Hornik},
	title = {cluster: Cluster Analysis Basics and Extensions},
	year = {2022},
	url = {https://cran.r-project.org/package=cluster},
	note = {Versión 2.1.5}
}

@manual{factoextra,
	author = {Alboukadel Kassambara y Fabian Mundt},
	title = {factoextra: Extract and Visualize the Results of Multivariate Data Analyses},
	year = {2017},
	url = {https://cran.r-project.org/package=factoextra},
	note = {Versión 1.0.8}
}

@manual{wgcna,
	author = {Peter Langfelder y Steve Horvath},
	title = {WGCNA: Weighted Correlation Network Analysis},
	year = {2008},
	url = {https://cran.r-project.org/package=WGCNA},
	note = {Versión 1.71}
}

@manual{igraph,
	author = {Gábor Csárdi y Tamás Nepusz},
	title = {igraph: Network Analysis and Visualization},
	year = {2006},
	url = {https://igraph.org/r/},
	note = {Versión 1.5.0}
}

@manual{stringdb,
	author = {Damian Szklarczyk, Annika L. Gable, David Lyon, Alexander Junge, Stefan Wyder, Jaime Huerta-Cepas, Milan Simonovic, Nadezhda T. Doncheva, John H. Morris, Peer Bork y otros},
	title = {STRINGdb: Functional Protein Association Networks},
	year = {2019},
	url = {https://cran.r-project.org/package=STRINGdb},
	note = {Versión 2.10.0}
}

@manual{pathview,
	author = {Weijun Luo y Cory Brouwer},
	title = {Pathview: An R/Bioconductor package for pathway-based data integration and visualization},
	year = {2013},
	url = {https://bioconductor.org/packages/pathview/},
	note = {Versión 1.36.0}
}

@manual{clusterprofiler,
	author = {Guangchuang Yu, Li-Gen Wang, Yanyan Han y Qing-Yu He},
	title = {clusterProfiler: An R package for comparing biological themes among gene clusters},
	year = {2012},
	url = {https://bioconductor.org/packages/clusterProfiler/},
	note = {Versión 4.15.0}
}

% ----------------------------------------------------------
% CLUSTERING

% Mario, clustering
@article{igraph,
	author = {Gábor Csárdi and Tamás Nepusz},
	title = {The igraph software package for complex network research},
	journal = {InterJournal Complex Systems},
	volume = {1695},
	year = {2006},
	doi = {10.5281/zenodo.3630268}
}

% Mario, clustering, algoritmo de Louvain
@article{Blondel2008Louvain,
	author = {Vincent D. Blondel and Jean Loup Guillaume and Renaud Lambiotte and Etienne Lefebvre},
	doi = {10.1088/1742-5468/2008/10/p10008},
	issn = {17425468},
	issue = {10},
	journal = {Journal of Statistical Mechanics: Theory and Experiment},
	keywords = {Networks,New applications of statistical mechanics,Random graphs},
	month = {3},
	note = {Algoritmo de Louvain en clustering},
	title = {Fast unfolding of communities in large networks},
	volume = {2008},
	url = {https://arxiv.org/abs/0803.0476v2},
	year = {2008},
}

% Mario, clustering, algoritmo de Leiden
@article{traag2019leiden,
	title={From Louvain to Leiden: guaranteeing well-connected communities},
	author={Traag, Vincent A and Waltman, Ludo and Van Eck, Nees Jan},
	journal={Scientific reports},
	volume={9},
	number={1},
	pages={1--12},
	year={2019},
	publisher={Nature Publishing Group}
}
% Mario, clustering, constant plotts model
@article{constantplottsmodel,
	title = {Narrow scope for resolution-limit-free community detection},
	author = {Traag, V. A. and Van Dooren, P. and Nesterov, Y.},
	journal = {Phys. Rev. E},
	volume = {84},
	issue = {1},
	pages = {016114},
	numpages = {9},
	year = {2011},
	month = {Jul},
	publisher = {American Physical Society},
	doi = {10.1103/PhysRevE.84.016114},
	url = {https://link.aps.org/doi/10.1103/PhysRevE.84.016114}
}

% Mario, clustering, algoritmo walktrap
@inproceedings{pons2005walktrap,
	title={Computing communities in large networks using random walks},
	author={Pons, Pascal and Latapy, Matthieu},
	booktitle={Computer and Information Sciences-ISCIS 2005: 20th International Symposium, Istanbul, Turkey, October 26-28, 2005. Proceedings 20},
	pages={284--293},
	year={2005},
	organization={Springer}
}

% Mario, clustering, stringdb
@article{szklarczyk2023stringdb,
	author = {Szklarczyk, Damian and Kirsch, Robin and Koutrouli, Magda and Nastou, Katerina and Mehryary, Farrokh and Hachilif, Rima and Gable, Annika L and Fang, Tao and Doncheva, Nadezhda T and Pyysalo, Sampo and Bork, Peer and Jensen, Lars J and von Mering, Christian},
	title = {The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest},
	journal = {Nucleic Acids Research},
	volume = {51},
	number = {D1},
	pages = {D638-D646},
	year = {2023},
	month = {January},
	doi = {10.1093/nar/gkac1000},
	pmid = {36370105},
	pmcid = {PMC9825434}
}

% Mario, clustering, pareto front 1
@book{goodarzi2014PARETOFRONT1,
	author = {Goodarzi, Ehsan and Ziaei, Mojtaba and Hosseinipour, Ehsan Zare},
	title = {Introduction to Optimization Analysis in Hydrosystem Engineering},
	publisher = {Springer},
	address = {Berlin/Heidelberg},
	year = {2014},
	pages = {111--148}
}

% Mario, clustering, pareto front 2
@book{jahan2013multiPARETOFRONT2,
	author = {Jahan, Ali and Edwards, Kip L. and Bahraminasab, Mohsen},
	title = {Multi-criteria Decision Analysis},
	edition = {2nd},
	publisher = {Elsevier},
	address = {Amsterdam},
	year = {2013},
	pages = {63--65}
}

% Mario, clustering, pareto front 3
@incollection{costa2015paretoPARETOFRONT3,
	author = {Costa, Nuno R. and Lourenço, José A.},
	title = {Exploring Pareto Frontiers in the Response Surface Methodology},
	booktitle = {Transactions on Engineering Technologies: World Congress on Engineering 2014},
	editor = {Yang, Gi-Chul and Ao, Sio-Iong and Gelman, Len},
	publisher = {Springer},
	address = {Berlin/Heidelberg},
	year = {2015},
	pages = {399--412}
}

%Carmen, análisis de enriquecimiento
@article{Tipney2010,
	author    = {Hannah Tipney and Lawrence Hunter},
	title     = {An introduction to effective use of enrichment analysis software},
	journal   = {Human Genomics},
	year      = {2010},
	volume    = {4},
	number    = {3},
	pages     = {202},
	doi       = {10.1186/1479-7364-4-3-202},
	url       = {https://doi.org/10.1186/1479-7364-4-3-202},
	issn      = {1479-7364},
	abstract  = {In recent years, there has been an explosion in the range of software available for annotation enrichment analysis. Three classes of enrichment algorithms and their associated software implementations are introduced here.},
}
#https://humgenomics.biomedcentral.com/articles/10.1186/1479-7364-4-3-202#citeas


@article{Reimand2019,
	author = {Reimand, Jüri and Isserlin, Ruth and Voisin, Veronique and Kucera, Mike and Tannus-Lopes, Christian and Rostamianfar, Asha and Wadi, Lina and Meyer, Mona and Wong, Jeff and Xu, Changjiang and Merico, Daniele and Bader, Gary D.},
	title = {Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap},
	journal = {Nature Protocols},
	year = {2019},
	volume = {14},
	number = {2},
	pages = {482--517},
	date = {2019/02/01},
	issn = {1750-2799},
	doi = {10.1038/s41596-018-0103-9},
	url = {https://doi.org/10.1038/s41596-018-0103-9}
}

#https://www.nature.com/articles/s41596-018-0103-9#citeas


@article{Szklarczyk2023,
	abstract = {Much of the complexity within cells arises from functional and regulatory interactions among proteins. The core of these interactions is increasingly known, but novel interactions continue to be discovered, and the information remains scattered across different database resources, experimental modalities and levels of mechanistic detail. The STRING database (https://string-db.org/) systematically collects and integrates protein-protein interactions - both physical interactions as well as functional associations. The data originate from a number of sources: automated text mining of the scientific literature, computational interaction predictions from co-expression, conserved genomic context, databases of interaction experiments and known complexes/pathways from curated sources. All of these interactions are critically assessed, scored, and subsequently automatically transferred to less well-studied organisms using hierarchical orthology information. The data can be accessed via the website, but also programmatically and via bulk downloads. The most recent developments in STRING (version 12.0) are: (i) it is now possible to create, browse and analyze a full interaction network for any novel genome of interest, by submitting its complement of encoded proteins, (ii) the co-expression channel now uses variational auto-encoders to predict interactions, and it covers two new sources, single-cell RNA-seq and experimental proteomics data and (iii) the confidence in each experimentally derived interaction is now estimated based on the detection method used, and communicated to the user in the web-interface. Furthermore, STRING continues to enhance its facilities for functional enrichment analysis, which are now fully available also for user-submitted genomes.},
	author = {Damian Szklarczyk and Rebecca Kirsch and Mikaela Koutrouli and Katerina Nastou and Farrokh Mehryary and Radja Hachilif and Annika L. Gable and Tao Fang and Nadezhda T. Doncheva and Sampo Pyysalo and Peer Bork and Lars J. Jensen and Christian Von Mering},
	doi = {10.1093/NAR/GKAC1000},
	issn = {1362-4962},
	issue = {D1},
	journal = {Nucleic acids research},
	keywords = {Christian von Mering,Damian Szklarczyk,Databases,Genomics,MEDLINE,NCBI,NIH,NLM,National Center for Biotechnology Information,National Institutes of Health,National Library of Medicine,Non-U.S. Gov't,PMC9825434,Protein,Protein Interaction Mapping* / methods,Proteins* / genetics,Proteins* / metabolism,Proteomics,PubMed Abstract,Rebecca Kirsch,Research Support,User-Computer Interface,doi:10.1093/nar/gkac1000,pmid:36370105},
	month = {1},
	pages = {D638-D646},
	pmid = {36370105},
	publisher = {Nucleic Acids Res},
	title = {The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest},
	volume = {51},
	url = {https://pubmed.ncbi.nlm.nih.gov/36370105/},
	year = {2023},
}
%https://www.bioconductor.org/packages/release/bioc/vignettes/STRINGdb/inst/doc/STRINGdb.pdf

